Breakthrough in High Sensitivity Tuberculosis and Malaria Diagnostics

    GOERLITZ, Germany, Nov. 14 /CNW/ - At this year's 39th World Forum for
Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading
developer, manufacturer and provider of dedicated diagnostic solutions in the
response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough
innovation for high sensitivity TB and Malaria diagnostics in low-and
middle-income countries.
    Until today, efforts in the challenge to address the urgent needs for
increasing patient coverage suffered from the massive bottleneck of missing
available diagnostic tools which would be feasible for routine use in regions
with low or difficult infrastructure. By combining the worldwide first
battery-operated and mobile fluorescence microscope "CyScope", developed by
Partec, with dedicated test kits, for the first time diagnostic services are
being offered in high burden countries also to those patients living far from
the few capital and large cities in remote areas.
    "The prerequisite for any improvement of treatment programmes in the TB
and Malaria field is the availability of diagnostic solutions adapted to the
specific regional situation and infrastructure, especially in developing
countries. By having successfully introduced an entirely new class of highly
affordable, ultracompact as well as robust and easy-to-use mobile fluorescence
microscopes, it is now possible to reach the many infected individuals who
previously have stayed almost completely uncovered from any testing for TB and
Malaria," said Roland Gohde, Chief Executive Officer of Partec Essential
Healthcare. "Due to the development in modern component technology it was
possible to design a unique compact microscope unit based on an innovative
optical system and new ultra-bright light-emitting diodes (LEDs), offering
significant benefits not only in terms of sensitivity, durability and
robustness, but in addition making available fluorescence microscopy at
instrument cost below EUR 1000." Conventional fluorescence microscopes usually
are in the range of above EUR 15.000.
    Besides the fluorescence microscopes, also the required TB and Malaria
test kits, approved for in vitro diagnostic use (IVD), are available from
Partec. For the TB reagents, a cooperation with Merck in Darmstadt, Germany,
has been entered. Merck, producing highly suitable TB staining kits, is a
globally leading pharmaceutical and chemical company with a tradition of over
300 years.
    The CyScope is already widely in use in Africa, Asia and Europe and has
been clinically validated with very positive results, both for TB and Malaria,
by different international research groups, e.g. in Ghana, Benin, French
Guyana, Nigeria and by the worldwide renowned and reputable
Bernhard-Nocht-Institute for Tropical Medicine in Hamburg. In June 2007, the
CyScope was honoured with the IQ Innovation Award Central Germany.

    Picture is available via EPA (European Pressphoto Agency) and can be
downloaded free of charge at:

    Partec GmbH
    Mrs. Claudia Khmel
    Fon +49-3581-8746-0

    Source: Partec GmbH

For further information:

For further information: Partec GmbH: Mrs. Claudia Khmel, Fon
+49-3581-8746-0, Mail

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890